+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Human Serum & Plasma Market - Global Forecast 2026-2032- Product Image
Human Serum & Plasma Market - Global Forecast 2026-2032- Product Image
Sale

Human Serum & Plasma Market - Global Forecast 2026-2032

  • Report

  • 192 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6124436
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Human Serum & Plasma Market is projected to reach USD 25.51 Billion in 2026. It is expected to continue growing at a CAGR of 9.25%, reaching USD 43.28 Billion by 2032.

Human Serum and Plasma: Executive Summary

Human serum and plasma are foundational biological materials used in diagnostics, therapeutics development, translational research, biobanking, and quality-control workflows. Their value depends on traceability, donor safety, biological consistency, validated processing, and suitability for increasingly specialized applications. The field is shaped by tighter oversight, more demanding characterization requirements, and the need to connect collection practices with reproducible downstream performance.

Regulatory Rigor and Specialized Demand Are Reshaping the Landscape

The landscape is shifting from volume-oriented collection toward quality-defined, application-specific materials. Greater attention to pathogen risk, donor eligibility, consent, chain of custody, cold-chain integrity, and lot characterization is raising operational requirements across collection and processing networks. At the same time, demand is becoming more specialized as laboratories seek matrices tailored to immunology, infectious-disease research, oncology, precision medicine, and assay development. Harmonized documentation and interoperable digital records are increasingly important for cross-border research and regulated use.

Artificial Intelligence Strengthens Characterization, Operations, and Quality Control

Artificial intelligence can improve the cumulative performance of serum and plasma workflows by supporting donor and sample metadata review, anomaly detection, inventory prioritization, assay-data interpretation, and predictive maintenance of processing systems. Machine-learning tools can help identify relationships between pre-analytical variables and downstream assay behavior, while computer vision and automated checks may reduce handling errors. These benefits depend on representative training data, validated models, human oversight, cybersecurity, and clear accountability. AI should complement-not replace-laboratory controls, biosafety procedures, and scientifically justified acceptance criteria.

Regional Insights: Regulation, Infrastructure, and Access Create Distinct Priorities

North America benefits from mature biomedical research infrastructure and strong demand for characterized specimens, while compliance, consent, and privacy requirements remain central. Europe emphasizes harmonized quality systems, ethical governance, and cross-border data and sample handling, with the European Union providing an important regulatory context. Asia-Pacific combines advanced research capabilities in several economies with fast-expanding diagnostic and biopharmaceutical activity, although infrastructure and standards vary. Latin America presents opportunities linked to diverse populations and growing research capacity, alongside uneven cold-chain access and regulatory consistency. The Middle East is investing in healthcare modernization and specialized research, with localization and biobanking capacity as recurring priorities. Africa offers important population diversity and unmet research needs, but sustainable collection networks, laboratory infrastructure, training, and equitable governance remain essential.

Group Insights: Economic and Security Alliances Influence Collaboration

ASEAN economies are connected by expanding healthcare and research collaboration, yet differ in regulatory maturity, logistics, and laboratory capacity. BRICS members bring substantial population diversity and research potential, while standards, procurement systems, and cross-border sample governance are not uniform. The European Union supports coordinated approaches to ethics, data protection, and quality management across participating countries. G7 members generally combine advanced research ecosystems with stringent regulatory and privacy expectations. GCC states are strengthening healthcare infrastructure and may prioritize centralized biobanking, localization, and high-specification laboratory capabilities. NATO countries span diverse health systems, but shared attention to resilience, biosafety, supply continuity, and emergency preparedness can support collaboration in biological-material workflows.

Country Insights: Diverse Capabilities Require Localized Operating Models

Australia combines strong biomedical research with geographic logistics considerations. Brazil offers substantial population diversity and growing research capacity, while regional infrastructure differences matter. Canada has robust academic and healthcare institutions, with privacy, consent, and cold-chain coordination remaining important. China continues to develop advanced biomedical capabilities within a distinct regulatory and data-governance environment. France, Germany, Italy, and Spain operate within European quality, ethics, and data frameworks while maintaining country-specific institutional practices. India has a large and diverse population base and expanding diagnostic and research activity, alongside varied infrastructure. Japan and South Korea pair sophisticated life-science ecosystems with high expectations for quality and technological integration. Mexico is strengthening healthcare and research capacity, with logistics and standardization requiring attention. Russia’s operating environment is shaped by national regulation, institutional capacity, and international access constraints. The United Kingdom retains significant biomedical expertise, with rigorous governance and post-EU cross-border considerations. The United States has extensive research, diagnostic, and biopharmaceutical infrastructure, alongside demanding requirements for compliance, privacy, and traceability.

Action Priorities for Leaders: Build Trustworthy, Data-Rich, Resilient Workflows

Industry leaders should establish risk-based quality systems that connect donor qualification, collection, processing, storage, testing, and release decisions. Standardized metadata, unique sample identifiers, validated cold-chain monitoring, and auditable chain-of-custody records can improve reproducibility. Organizations should segment materials by intended use and define fit-for-purpose acceptance criteria rather than relying on generic specifications. Regional partnerships can strengthen access while supporting local capability, ethical benefit sharing, and continuity planning. AI investments should begin with well-governed use cases such as inventory intelligence and quality anomaly detection, supported by independent validation and human review. Leaders should also maintain diversified logistics, transparent consent practices, cybersecurity controls, and routine supplier and facility assessments.

Research Methodology: Evidence-Based Synthesis of the Human Serum and Plasma Field

This executive summary uses a structured qualitative synthesis focused on the role of human serum and plasma across research, diagnostics, therapeutics development, biobanking, and quality control. The assessment organizes evidence around regulatory expectations, pre-analytical quality, infrastructure, data governance, digital transformation, artificial intelligence, and regional operating conditions. Regional, group, and country narratives are integrated to reflect differences in healthcare capacity, research ecosystems, logistics, ethics, and oversight. Conclusions are limited to established industry dynamics and do not include market estimates, market sizing, market shares, or forecasts.

Conclusion: Quality, Governance, and Interoperability Will Define Sustainable Progress

Human serum and plasma will remain critical to biological research and healthcare innovation, but dependable value will increasingly come from verified quality rather than material availability alone. Organizations that combine rigorous donor and sample governance with interoperable data, resilient infrastructure, and fit-for-purpose characterization will be better positioned to support reproducible science. Artificial intelligence can accelerate these improvements when deployed within validated, transparent, and human-supervised systems. Progress across regions and country groups will depend on collaboration that protects donors, respects local governance, and expands equitable access to high-quality biological materials.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Human Serum & Plasma Market, by Component
7.1. Introduction
7.2. Plasma
7.3. Serum
8. Human Serum & Plasma Market, by Product Type
8.1. Introduction
8.2. Instruments
8.3. Kits
8.4. Reagents
8.5. Services
9. Human Serum & Plasma Market, by Technique
9.1. Introduction
9.2. Chromatography
9.3. Flow Cytometry
9.4. Immunoassay
9.5. Mass Spectrometry
9.6. Western Blot
10. Human Serum & Plasma Market, by Application
10.1. Introduction
10.2. Diagnostics
10.2.1. Cardiology
10.2.2. Infectious Diseases
10.2.3. Neurology
10.2.4. Oncology
10.3. Research
10.4. Therapeutics
11. Human Serum & Plasma Market, by End User
11.1. Introduction
11.2. Academic Institutes
11.3. Diagnostic Laboratories
11.4. Hospitals
11.5. Research Laboratories
12. Human Serum & Plasma Market, by Distribution Channel
12.1. Introduction
12.2. Offline
12.3. Online
13. Human Serum & Plasma Market, by Region
13.1. Introduction
13.2. Asia-Pacific
13.3. North America
13.4. Latin America
13.5. Europe
13.6. Middle East
13.7. Africa
14. Human Serum & Plasma Market, by Group
14.1. Introduction
14.2. ASEAN
14.3. GCC
14.4. European Union
14.5. BRICS
14.6. G7
14.7. NATO
15. Human Serum & Plasma Market, by Country
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. United Kingdom
15.7. Germany
15.8. France
15.9. Russia
15.10. Italy
15.11. Spain
15.12. China
15.13. India
15.14. Japan
15.15. Australia
15.16. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. Market Concentration Analysis, 2025
16.2.1. Concentration Ratio (CR)
16.2.2. Herfindahl Hirschman Index (HHI)
16.3. Recent Developments & Impact Analysis, 2025
16.4. Product Portfolio Analysis, 2025
16.5. Benchmarking Analysis, 2025
17. Company Profiles
17.1. Baxter International Inc.
17.2. Bio Products Laboratory Limited
17.3. Biotest AG
17.4. CSL Limited
17.5. Grifols, S.A.
17.6. Kedrion S.p.A.
17.7. LFB S.A.
17.8. Octapharma AG
17.9. Reliance Life Sciences
17.10. Sanquin Plasma Products B.V.
17.11. Shanghai RAAS Blood Products Co., Ltd.
17.12. Takeda Pharmaceutical Company Limited
18. Key Experts
LIST OF FIGURES
FIGURE 1. Global Human Serum & Plasma Market, Years Considered for the Study
FIGURE 2. Global Human Serum & Plasma Market, Research Design
FIGURE 3. Global Human Serum & Plasma Market, Research Framework
FIGURE 4. Global Human Serum & Plasma Market, Data Triangulation
FIGURE 5. Global Human Serum & Plasma Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Human Serum & Plasma Market Size, by Component, 2025 vs 2032 (%)
FIGURE 7. Global Human Serum & Plasma Market Size, by Component, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Human Serum & Plasma Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 9. Global Human Serum & Plasma Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Human Serum & Plasma Market Size, by Technique, 2025 vs 2032 (%)
FIGURE 11. Global Human Serum & Plasma Market Size, by Technique, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Human Serum & Plasma Market Size, by Application, 2025 vs 2032 (%)
FIGURE 13. Global Human Serum & Plasma Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Human Serum & Plasma Market Size, by End User, 2025 vs 2032 (%)
FIGURE 15. Global Human Serum & Plasma Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Human Serum & Plasma Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 17. Global Human Serum & Plasma Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Human Serum & Plasma Market Size, by Region, 2025 vs 2032 (%)
FIGURE 19. Global Human Serum & Plasma Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global Human Serum & Plasma Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Human Serum & Plasma Market Size, by Country, 2025 vs 2032 (%)
FIGURE 22. Global Human Serum & Plasma Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 23. Global Human Serum & Plasma Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Human Serum & Plasma Market Segmentation & Coverage
TABLE 2. Global Human Serum & Plasma Market Size, 2017-2032 (USD Million)
TABLE 3. Global Human Serum & Plasma Market Size, by Component, 2017-2032 (USD Million)
TABLE 4. Global Plasma Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Plasma Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Plasma Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Serum Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Serum Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Serum Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Human Serum & Plasma Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 11. Global Instruments Market Size, by Region, 2017-2032 (USD Million)
TABLE 12. Global Instruments Market Size, by Group, 2017-2032 (USD Million)
TABLE 13. Global Instruments Market Size, by Country, 2017-2032 (USD Million)
TABLE 14. Global Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 15. Global Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 16. Global Kits Market Size, by Country, 2017-2032 (USD Million)
TABLE 17. Global Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Reagents Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Human Serum & Plasma Market Size, by Technique, 2017-2032 (USD Million)
TABLE 24. Global Chromatography Market Size, by Region, 2017-2032 (USD Million)
TABLE 25. Global Chromatography Market Size, by Group, 2017-2032 (USD Million)
TABLE 26. Global Chromatography Market Size, by Country, 2017-2032 (USD Million)
TABLE 27. Global Flow Cytometry Market Size, by Region, 2017-2032 (USD Million)
TABLE 28. Global Flow Cytometry Market Size, by Group, 2017-2032 (USD Million)
TABLE 29. Global Flow Cytometry Market Size, by Country, 2017-2032 (USD Million)
TABLE 30. Global Immunoassay Market Size, by Region, 2017-2032 (USD Million)
TABLE 31. Global Immunoassay Market Size, by Group, 2017-2032 (USD Million)
TABLE 32. Global Immunoassay Market Size, by Country, 2017-2032 (USD Million)
TABLE 33. Global Mass Spectrometry Market Size, by Region, 2017-2032 (USD Million)
TABLE 34. Global Mass Spectrometry Market Size, by Group, 2017-2032 (USD Million)
TABLE 35. Global Mass Spectrometry Market Size, by Country, 2017-2032 (USD Million)
TABLE 36. Global Western Blot Market Size, by Region, 2017-2032 (USD Million)
TABLE 37. Global Western Blot Market Size, by Group, 2017-2032 (USD Million)
TABLE 38. Global Western Blot Market Size, by Country, 2017-2032 (USD Million)
TABLE 39. Global Human Serum & Plasma Market Size, by Application, 2017-2032 (USD Million)
TABLE 40. Global Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Diagnostics Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Cardiology Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Cardiology Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Cardiology Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Infectious Diseases Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Infectious Diseases Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Infectious Diseases Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Neurology Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Neurology Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Neurology Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Oncology Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Global Oncology Market Size, by Group, 2017-2032 (USD Million)
TABLE 54. Global Oncology Market Size, by Country, 2017-2032 (USD Million)
TABLE 55. Global Research Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. Global Research Market Size, by Group, 2017-2032 (USD Million)
TABLE 57. Global Research Market Size, by Country, 2017-2032 (USD Million)
TABLE 58. Global Therapeutics Market Size, by Region, 2017-2032 (USD Million)
TABLE 59. Global Therapeutics Market Size, by Group, 2017-2032 (USD Million)
TABLE 60. Global Therapeutics Market Size, by Country, 2017-2032 (USD Million)
TABLE 61. Global Human Serum & Plasma Market Size, by End User, 2017-2032 (USD Million)
TABLE 62. Global Academic Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Global Academic Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 64. Global Academic Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 65. Global Diagnostic Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Global Diagnostic Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 67. Global Diagnostic Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 68. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 70. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 71. Global Research Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 72. Global Research Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 73. Global Research Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 74. Global Human Serum & Plasma Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 75. Global Offline Market Size, by Region, 2017-2032 (USD Million)
TABLE 76. Global Offline Market Size, by Group, 2017-2032 (USD Million)
TABLE 77. Global Offline Market Size, by Country, 2017-2032 (USD Million)
TABLE 78. Global Online Market Size, by Region, 2017-2032 (USD Million)
TABLE 79. Global Online Market Size, by Group, 2017-2032 (USD Million)
TABLE 80. Global Online Market Size, by Country, 2017-2032 (USD Million)
TABLE 81. Global Human Serum & Plasma Market Size, by Region, 2017-2032 (USD Million)
TABLE 82. Asia-Pacific Human Serum & Plasma Market Size, by Region, 2017-2032 (USD Million)
TABLE 83. Asia-Pacific Human Serum & Plasma Market Size, by Component, 2017-2032 (USD Million)
TABLE 84. Asia-Pacific Human Serum & Plasma Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 85. Asia-Pacific Human Serum & Plasma Market Size, by Technique, 2017-2032 (USD Million)
TABLE 86. Asia-Pacific Human Serum & Plasma Market Size, by Application, 2017-2032 (USD Million)
TABLE 87. Asia-Pacific Human Serum & Plasma Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 88. Asia-Pacific Human Serum & Plasma Market Size, by End User, 2017-2032 (USD Million)
TABLE 89. Asia-Pacific Human Serum & Plasma Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 90. North America Human Serum & Plasma Market Size, by Region, 2017-2032 (USD Million)
TABLE 91. North America Human Serum & Plasma Market Size, by Component, 2017-2032 (USD Million)
TABLE 92. North America Human Serum & Plasma Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 93. North America Human Serum & Plasma Market Size, by Technique, 2017-2032 (USD Million)
TABLE 94. North America Human Serum & Plasma Market Size, by Application, 2017-2032 (USD Million)
TABLE 95. North America Human Serum & Plasma Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 96. North America Human Serum & Plasma Market Size, by End User, 2017-2032 (USD Million)
TABLE 97. North America Human Serum & Plasma Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 98. Latin America Human Serum & Plasma Market Size, by Region, 2017-2032 (USD Million)
TABLE 99. Latin America Human Serum & Plasma Market Size, by Component, 2017-2032 (USD Million)
TABLE 100. Latin America Human Serum & Plasma Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 101. Latin America Human Serum & Plasma Market Size, by Technique, 2017-2032 (USD Million)
TABLE 102. Latin America Human Serum & Plasma Market Size, by Application, 2017-2032 (USD Million)
TABLE 103. Latin America Human Serum & Plasma Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 104. Latin America Human Serum & Plasma Market Size, by End User, 2017-2032 (USD Million)
TABLE 105. Latin America Human Serum & Plasma Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 106. Europe Human Serum & Plasma Market Size, by Region, 2017-2032 (USD Million)
TABLE 107. Europe Human Serum & Plasma Market Size, by Component, 2017-2032 (USD Million)
TABLE 108. Europe Human Serum & Plasma Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 109. Europe Human Serum & Plasma Market Size, by Technique, 2017-2032 (USD Million)
TABLE 110. Europe Human Serum & Plasma Market Size, by Application, 2017-2032 (USD Million)
TABLE 111. Europe Human Serum & Plasma Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 112. Europe Human Serum & Plasma Market Size, by End User, 2017-2032 (USD Million)
TABLE 113. Europe Human Serum & Plasma Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 114. Middle East Human Serum & Plasma Market Size, by Region, 2017-2032 (USD Million)
TABLE 115. Middle East Human Serum & Plasma Market Size, by Component, 2017-2032 (USD Million)
TABLE 116. Middle East Human Serum & Plasma Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 117. Middle East Human Serum & Plasma Market Size, by Technique, 2017-2032 (USD Million)
TABLE 118. Middle East Human Serum & Plasma Market Size, by Application, 2017-2032 (USD Million)
TABLE 119. Middle East Human Serum & Plasma Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 120. Middle East Human Serum & Plasma Market Size, by End User, 2017-2032 (USD Million)
TABLE 121. Middle East Human Serum & Plasma Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 122. Africa Human Serum & Plasma Market Size, by Region, 2017-2032 (USD Million)
TABLE 123. Africa Human Serum & Plasma Market Size, by Component, 2017-2032 (USD Million)
TABLE 124. Africa Human Serum & Plasma Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 125. Africa Human Serum & Plasma Market Size, by Technique, 2017-2032 (USD Million)
TABLE 126. Africa Human Serum & Plasma Market Size, by Application, 2017-2032 (USD Million)
TABLE 127. Africa Human Serum & Plasma Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 128. Africa Human Serum & Plasma Market Size, by End User, 2017-2032 (USD Million)
TABLE 129. Africa Human Serum & Plasma Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 130. Global Human Serum & Plasma Market Size, by Group, 2017-2032 (USD Million)
TABLE 131. ASEAN Human Serum & Plasma Market Size, by Group, 2017-2032 (USD Million)
TABLE 132. ASEAN Human Serum & Plasma Market Size, by Component, 2017-2032 (USD Million)
TABLE 133. ASEAN Human Serum & Plasma Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 134. ASEAN Human Serum & Plasma Market Size, by Technique, 2017-2032 (USD Million)
TABLE 135. ASEAN Human Serum & Plasma Market Size, by Application, 2017-2032 (USD Million)
TABLE 136. ASEAN Human Serum & Plasma Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 137. ASEAN Human Serum & Plasma Market Size, by End User, 2017-2032 (USD Million)
TABLE 138. ASEAN Human Serum & Plasma Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 139. GCC Human Serum & Plasma Market Size, by Group, 2017-2032 (USD Million)
TABLE 140. GCC Human Serum & Plasma Market Size, by Component, 2017-2032 (USD Million)
TABLE 141. GCC Human Serum & Plasma Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 142. GCC Human Serum & Plasma Market Size, by Technique, 2017-2032 (USD Million)
TABLE 143. GCC Human Serum & Plasma Market Size, by Application, 2017-2032 (USD Million)
TABLE 144. GCC Human Serum & Plasma Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 145. GCC Human Serum & Plasma Market Size, by End User, 2017-2032 (USD Million)
TABLE 146. GCC Human Serum & Plasma Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 147. European Union Human Serum & Plasma Market Size, by Group, 2017-2032 (USD Million)
TABLE 148. European Union Human Serum & Plasma Market Size, by Component, 2017-2032 (USD Million)
TABLE 149. European Union Human Serum & Plasma Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 150. European Union Human Serum & Plasma Market Size, by Technique, 2017-2032 (USD Million)
TABLE 151. European Union Human Serum & Plasma Market Size, by Application, 2017-2032 (USD Million)
TABLE 152. European Union Human Serum & Plasma Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 153. European Union Human Serum & Plasma Market Size, by End User, 2017-2032 (USD Million)
TABLE 154. European Union Human Serum & Plasma Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 155. BRICS Human Serum & Plasma Market Size, by Group, 2017-2032 (USD Million)
TABLE 156. BRICS Human Serum & Plasma Market Size, by Component, 2017-2032 (USD Million)
TABLE 157. BRICS Human Serum & Plasma Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 158. BRICS Human Serum & Plasma Market Size, by Technique, 2017-2032 (USD Million)
TABLE 159. BRICS Human Serum & Plasma Market Size, by Application, 2017-2032 (USD Million)
TABLE 160. BRICS Human Serum & Plasma Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 161. BRICS Human Serum & Plasma Market Size, by End User, 2017-2032 (USD Million)
TABLE 162. BRICS Human Serum & Plasma Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 163. G7 Human Serum & Plasma Market Size, by Group, 2017-2032 (USD Million)
TABLE 164. G7 Human Serum & Plasma Market Size, by Component, 2017-2032 (USD Million)
TABLE 165. G7 Human Serum & Plasma Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 166. G7 Human Serum & Plasma Market Size, by Technique, 2017-2032 (USD Million)
TABLE 167. G7 Human Serum & Plasma Market Size, by Application, 2017-2032 (USD Million)
TABLE 168. G7 Human Serum & Plasma Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 169. G7 Human Serum & Plasma Market Size, by End User, 2017-2032 (USD Million)
TABLE 170. G7 Human Serum & Plasma Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 171. NATO Human Serum & Plasma Market Size, by Group, 2017-2032 (USD Million)
TABLE 172. NATO Human Serum & Plasma Market Size, by Component, 2017-2032 (USD Million)
TABLE 173. NATO Human Serum & Plasma Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 174. NATO Human Serum & Plasma Market Size, by Technique, 2017-2032 (USD Million)
TABLE 175. NATO Human Serum & Plasma Market Size, by Application, 2017-2032 (USD Million)
TABLE 176. NATO Human Serum & Plasma Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 177. NATO Human Serum & Plasma Market Size, by End User, 2017-2032 (USD Million)
TABLE 178. NATO Human Serum & Plasma Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 179. Global Human Serum & Plasma Market Size, by Country, 2017-2032 (USD Million)
TABLE 180. United States Human Serum & Plasma Market Size, 2017-2032 (USD Million)
TABLE 181. United States Human Serum & Plasma Market Size, by Component, 2017-2032 (USD Million)
TABLE 182. United States Human Serum & Plasma Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 183. United States Human Serum & Plasma Market Size, by Technique, 2017-2032 (USD Million)
TABLE 184. United States Human Serum & Plasma Market Size, by Application, 2017-2032 (USD Million)
TABLE 185. United States Human Serum & Plasma Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 186. United States Human Serum & Plasma Market Size, by End User, 2017-2032 (USD Million)
TABLE 187. United States Human Serum & Plasma Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 188. Canada Human Serum & Plasma Market Size, 2017-2032 (USD Million)
TABLE 189. Canada Human Serum & Plasma Market Size, by Component, 2017-2032 (USD Million)
TABLE 190. Canada Human Serum & Plasma Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 191. Canada Human Serum & Plasma Market Size, by Technique, 2017-2032 (USD Million)
TABLE 192. Canada Human Serum & Plasma Market Size, by Application, 2017-2032 (USD Million)
TABLE 193. Canada Human Serum & Plasma Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 194. Canada Human Serum & Plasma Market Size, by End User, 2017-2032 (USD Million)
TABLE 195. Canada Human Serum & Plasma Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 196. Mexico Human Serum & Plasma Market Size, 2017-2032 (USD Million)
TABLE 197. Mexico Human Serum & Plasma Market Size, by Component, 2017-2032 (USD Million)
TABLE 198. Mexico Human Serum & Plasma Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 199. Mexico Human Serum & Plasma Market Size, by Technique, 2017-2032 (USD Million)
TABLE 200. Mexico Human Serum & Plasma Market Size, by Application, 2017-2032 (USD Million)
TABLE 201. Mexico Human Serum & Plasma Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 202. Mexico Human Serum & Plasma Market Size, by End User, 2017-2032 (USD Million)
TABLE 203. Mexico Human Serum & Plasma Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 204. Brazil Human Serum & Plasma Market Size, 2017-2032 (USD Million)
TABLE 205. Brazil Human Serum & Plasma Market Size, by Component, 2017-2032 (USD Million)
TABLE 206. Brazil Human Serum & Plasma Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 207. Brazil Human Serum & Plasma Market Size, by Technique, 2017-2032 (USD Million)
TABLE 208. Brazil Human Serum & Plasma Market Size, by Application, 2017-2032 (USD Million)
TABLE 209. Brazil Human Serum & Plasma Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 210. Brazil Human Serum & Plasma Market Size, by End User, 2017-2032 (USD Million)
TABLE 211. Brazil Human Serum & Plasma Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 212. United Kingdom Human Serum & Plasma Market Size, 2017-2032 (USD Million)
TABLE 213. United Kingdom Human Serum & Plasma Market Size, by Component, 2017-2032 (USD Million)
TABLE 214. United Kingdom Human Serum & Plasma Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 215. United Kingdom Human Serum & Plasma Market Size, by Technique, 2017-2032 (USD Million)
TABLE 216. United Kingdom Human Serum & Plasma Market Size, by Application, 2017-2032 (USD Million)
TABLE 217. United Kingdom Human Serum & Plasma Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 218. United Kingdom Human Serum & Plasma Market Size, by End User, 2017-2032 (USD Million)
TABLE 219. United Kingdom Human Serum & Plasma Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 220. Germany Human Serum & Plasma Market Size, 2017-2032 (USD Million)
TABLE 221. Germany Human Serum & Plasma Market Size, by Component, 2017-2032 (USD Million)
TABLE 222. Germany Human Serum & Plasma Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 223. Germany Human Serum & Plasma Market Size, by Technique, 2017-2032 (USD Million)
TABLE 224. Germany Human Serum & Plasma Market Size, by Application, 2017-2032 (USD Million)
TABLE 225. Germany Human Serum & Plasma Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 226. Germany Human Serum & Plasma Market Size, by End User, 2017-2032 (USD Million)
TABLE 227. Germany Human Serum & Plasma Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 228. France Human Serum & Plasma Market Size, 2017-2032 (USD Million)
TABLE 229. France Human Serum & Plasma Market Size, by Component, 2017-2032 (USD Million)
TABLE 230. France Human Serum & Plasma Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 231. France Human Serum & Plasma Market Size, by Technique, 2017-2032 (USD Million)
TABLE 232. France Human Serum & Plasma Market Size, by Application, 2017-2032 (USD Million)
TABLE 233. France Human Serum & Plasma Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 234. France Human Serum & Plasma Market Size, by End User, 2017-2032 (USD Million)
TABLE 235. France Human Serum & Plasma Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 236. Russia Human Serum & Plasma Market Size, 2017-2032 (USD Million)
TABLE 237. Russia Human Serum & Plasma Market Size, by Component, 2017-2032 (USD Million)
TABLE 238. Russia Human Serum & Plasma Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 239. Russia Human Serum & Plasma Market Size, by Technique, 2017-2032 (USD Million)
TABLE 240. Russia Human Serum & Plasma Market Size, by Application, 2017-2032 (USD Million)
TABLE 241. Russia Human Serum & Plasma Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 242. Russia Human Serum & Plasma Market Size, by End User, 2017-2032 (USD Million)
TABLE 243. Russia Human Serum & Plasma Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 244. Italy Human Serum & Plasma Market Size, 2017-2032 (USD Million)
TABLE 245. Italy Human Serum & Plasma Market Size, by Component, 2017-2032 (USD Million)
TABLE 246. Italy Human Serum & Plasma Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 247. Italy Human Serum & Plasma Market Size, by Technique, 2017-2032 (USD Million)
TABLE 248. Italy Human Serum & Plasma Market Size, by Application, 2017-2032 (USD Million)
TABLE 249. Italy Human Serum & Plasma Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 250. Italy Human Serum & Plasma Market Size, by End User, 2017-2032 (USD Million)
TABLE 251. Italy Human Serum & Plasma Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 252. Spain Human Serum & Plasma Market Size, 2017-2032 (USD Million)
TABLE 253. Spain Human Serum & Plasma Market Size, by Component, 2017-2032 (USD Million)
TABLE 254. Spain Human Serum & Plasma Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 255. Spain Human Serum & Plasma Market Size, by Technique, 2017-2032 (USD Million)
TABLE 256. Spain Human Serum & Plasma Market Size, by Application, 2017-2032 (USD Million)
TABLE 257. Spain Human Serum & Plasma Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 258. Spain Human Serum & Plasma Market Size, by End User, 2017-2032 (USD Million)
TABLE 259. Spain Human Serum & Plasma Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 260. China Human Serum & Plasma Market Size, 2017-2032 (USD Million)
TABLE 261. China Human Serum & Plasma Market Size, by Component, 2017-2032 (USD Million)
TABLE 262. China Human Serum & Plasma Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 263. China Human Serum & Plasma Market Size, by Technique, 2017-2032 (USD Million)
TABLE 264. China Human Serum & Plasma Market Size, by Application, 2017-2032 (USD Million)
TABLE 265. China Human Serum & Plasma Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 266. China Human Serum & Plasma Market Size, by End User, 2017-2032 (USD Million)
TABLE 267. China Human Serum & Plasma Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 268. India Human Serum & Plasma Market Size, 2017-2032 (USD Million)
TABLE 269. India Human Serum & Plasma Market Size, by Component, 2017-2032 (USD Million)
TABLE 270. India Human Serum & Plasma Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 271. India Human Serum & Plasma Market Size, by Technique, 2017-2032 (USD Million)
TABLE 272. India Human Serum & Plasma Market Size, by Application, 2017-2032 (USD Million)
TABLE 273. India Human Serum & Plasma Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 274. India Human Serum & Plasma Market Size, by End User, 2017-2032 (USD Million)
TABLE 275. India Human Serum & Plasma Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 276. Japan Human Serum & Plasma Market Size, 2017-2032 (USD Million)
TABLE 277. Japan Human Serum & Plasma Market Size, by Component, 2017-2032 (USD Million)
TABLE 278. Japan Human Serum & Plasma Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 279. Japan Human Serum & Plasma Market Size, by Technique, 2017-2032 (USD Million)
TABLE 280. Japan Human Serum & Plasma Market Size, by Application, 2017-2032 (USD Million)
TABLE 281. Japan Human Serum & Plasma Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 282. Japan Human Serum & Plasma Market Size, by End User, 2017-2032 (USD Million)
TABLE 283. Japan Human Serum & Plasma Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 284. Australia Human Serum & Plasma Market Size, 2017-2032 (USD Million)
TABLE 285. Australia Human Serum & Plasma Market Size, by Component, 2017-2032 (USD Million)
TABLE 286. Australia Human Serum & Plasma Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 287. Australia Human Serum & Plasma Market Size, by Technique, 2017-2032 (USD Million)
TABLE 288. Australia Human Serum & Plasma Market Size, by Application, 2017-2032 (USD Million)
TABLE 289. Australia Human Serum & Plasma Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 290. Australia Human Serum & Plasma Market Size, by End User, 2017-2032 (USD Million)
TABLE 291. Australia Human Serum & Plasma Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 292. South Korea Human Serum & Plasma Market Size, 2017-2032 (USD Million)
TABLE 293. South Korea Human Serum & Plasma Market Size, by Component, 2017-2032 (USD Million)
TABLE 294. South Korea Human Serum & Plasma Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 295. South Korea Human Serum & Plasma Market Size, by Technique, 2017-2032 (USD Million)
TABLE 296. South Korea Human Serum & Plasma Market Size, by Application, 2017-2032 (USD Million)
TABLE 297. South Korea Human Serum & Plasma Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 298. South Korea Human Serum & Plasma Market Size, by End User, 2017-2032 (USD Million)
TABLE 299. South Korea Human Serum & Plasma Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 300. Global Human Serum & Plasma Market Share, by Key Player, 2025
TABLE 301. Global Human Serum & Plasma Market, Key Experts

Companies Mentioned

  • Baxter International Inc.
  • Bio Products Laboratory Limited
  • Biotest AG
  • CSL Limited
  • Grifols, S.A.
  • Kedrion S.p.A.
  • LFB S.A.
  • Octapharma AG
  • Reliance Life Sciences
  • Sanquin Plasma Products B.V.
  • Shanghai RAAS Blood Products Co., Ltd.
  • Takeda Pharmaceutical Company Limited

Related Topics

Related Reports

Goettingen Minipig Blood Products Market - Global Forecast 2026-2032 - Product Image

Goettingen Minipig Blood Products Market - Global Forecast 2026-2032

  • Report
  • 182 Pages
  • Global
From
Therapeutic Plasma Exchange Market - Global Forecast 2026-2032 - Product Image

Therapeutic Plasma Exchange Market - Global Forecast 2026-2032

  • Report
  • 186 Pages
  • Global
From
Blood Albumin Market Report: Trends, Forecast and Competitive Analysis to 2035 - Product Image

Blood Albumin Market Report: Trends, Forecast and Competitive Analysis to 2035

  • Report
  • 161 Pages
  • Global
From
Plasma Fractionation Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F - Product Image

Plasma Fractionation Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F

  • Report
  • 180 Pages
  • Global
From
Plasma Fractionation Market Report 2026 - Product Image

Plasma Fractionation Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.